Vidaza and renal failure Patient Reports February 11, 2012

Vidaza Side Effects Report #5646849-9
Vidaza side effect was reported by a Physician from ITALY on Feb 18, 2008. Male patient, 80 years of age, weighting 213.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: renal failure, sepsis . Vidaza dosage: (150 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with DEPAKIN. Patient was hospitalized. Patient died on 01/16/2008.

Vidaza Side Effects Report #5286019-X
Vidaza side effect was reported by a Physician from UNITED STATES on Mar 16, 2007. Male patient, 79 years of age, weighting 181.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atelectasis, hypotension, hypoxia, pleural effusion, productive cough, renal failure, sepsis , sputum discoloured, sputum purulent. Vidaza dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with METFORMIN, ASPIRIN, DOXYCYCLINE, GUAIFENESIN, POTASSIUM. Patient was hospitalized. Patient died on 03/17/2007.

Vidaza Side Effects Report #5166385-6
Vidaza side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 15, 2006. Male patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: haemorrhage, pneumonia , renal failure, sepsis . Vidaza dosage: unknown. Patient was hospitalized. Patient died on 02/01/2006.

Vidaza Side Effects Report #4867503-7
Vidaza side effect was reported by a Physician from UNITED STATES on Dec 08, 2005. Female patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: hypotension, injection site haemorrhage, injection site pain, intestinal ischaemia, multi-organ failure, renal failure, respiratory failure, sepsis , thrombosis mesenteric vessel. Vidaza dosage: 75 MG/M2 (DAILY X 5. Patient died on 08/23/2005.


Vidaza Side Effects Report #5467580-9
Vidaza side effect was reported by a Physician from UNITED STATES on Sept 07, 2007. Male patient, 43 years of age, weighting 242.5 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal pain , acute febrile neutrophilic dermatosis, post procedural haematoma, renal failure, respiratory failure, sepsis , vocal cord disorder. Vidaza dosage: (75 MG/M2, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with VORINOSTAT. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5942302-3
Vidaza side effect was reported by a Consumer or non-health professional from SPAIN on Oct 21, 2008. Male patient, weighting 149.9 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, colitis ischaemic, hypotension, renal failure. Vidaza dosage: unknown. During the same period patient was treated with TRANEXAMIC ACID, VANCOMYCIN, IMIPENEM, CASPOFUNGIN, VITAMIN B6, VORICONAZOLE, MAGNESIUM METAMIZOLE. Patient was hospitalized. Patient died on 09/21/2008.

Vidaza Side Effects Report #5913565-5
Vidaza side effect was reported by a Physician from SPAIN on Sept 29, 2008. Male patient, 75 years of age, weighting 149.9 lb, was diagnosed with fibrosis, myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, colitis ischaemic, hypotension, renal failure. Vidaza dosage: (75 MG/M2, X7 DAILY, SUBCUTANEOUS). During the same period patient was treated with TRANEXAMIC ACID, VANCOMYCIN, IMIPENEM, CASPOFUNGIN, VITAMIN B6, VORICONAZOLE, MAGNESIUM METAMIZOLE. Patient died on 09/21/2008.

Vidaza Side Effects Report #5762002-2
Vidaza side effect was reported by a Physician from FRANCE on May 20, 2008. Male patient, 50 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: blood creatinine increased, complications of bone marrow transplant, cytolytic hepatitis, renal failure. Vidaza dosage: 75 MG/M2, DAILY, SUBCUTANEOUS. During the same period patient was treated with ROVAMYCINE, VALACYCLOVIR, CORTICOSTEROIDS, GRANOCYTE, AUGMENTIN, AMOXICILLIN. Patient recovered.